Table 7: Univariate and multivariate analysis of factors for vulnerability associated with 30-day all-cause mortality.
|
Univariate Analysis |
Multivariate Analysis |
|
Variable |
30-Day All-Cause Mortality (%) |
OR (95% CI) p-value |
OR (95% CI) p-value |
Male |
6.1 |
2.20 (1.15-4.23) 0.015 |
2.50 (1.17-5.35) 0.019 |
Age ≥ 80 years |
7.3 |
2.78 (1.46-5.31) 0.001 |
1.71 (0.80-3.65) 0.167 |
Severe functional impairment (Katz Index ≤ 2) |
11.0 |
3.66 (1.73-7.63) < 0.001 |
3.43 (1.27-9.21) 0.015 |
Frailty with dependence (CFS ≥ 5) |
6.2 |
2.40 (1.24-4.63) 0.008 |
1.53 (0.65-3.60) 0.328 |
Presence of delirium/cognitive impairment (4AT ≥ 4) |
9.3 |
3.09 (1.35-7.07) 0.005 |
1.40 (0.51-3.85) 0.516 |
Severe COVID-19 Pneumonia (Stage 4 or 5) |
12.7 |
5.61 (2.91-10.79) < 0.001 |
3.74 (1.77-7.92) < 0.001 |
COVID-19 Decision Support Tool |
4.6 |
2.06 (0.72-5.86) 0.169 |
- |
Multiple Co-morbidities (CCI ≥ 3) |
4.2 |
1.81 (0.24-13.48) 0.559 |
- |
Polypharmacy (≥ 5 medications) |
14.4 |
1.23 (0.64-2.35) 0.534 |
- |
OR: Odds Ratio; CI: Confidence Interval